Аnti-money laundering policy Non disclosure agreement
Support Support

News Interim report on the use of Alginar.

Interim report on the use of Alginar.

Dear partners!
Interim report on the use of Alginar.

Research on the drug ALGINAR began on 07.02.2024, with 4 participants with different types of diseases involved.

Currently, all participants in the study feel satisfactory. Every Monday and Thursday, each participant sends a diary of well-being, describing their condition while taking the drug.
From the general observations, during the use of Alginar, the following effects were shown: improved sleep, energy boost, improved complexion and skin color, reduction of painful symptoms related to both the main disease and accompanying ones, overall improvement in well-being, and easier chemotherapy.

As of today, the research is ongoing, we will keep you updated!


Official resources:

United Financial Group  UFG market  Facebook  Telegram chat  You-t  VKontakte